Hu Li

27PUBLICATIONS
161CO-AUTHORS
Predictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)Cancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Feb 25, 2026
Biomarker for craving and acamprosate treatment response in patients with alcohol use disorder: insights from multi-omics.

Ming-Fen Ho, Cheng Zhang, Brandon J Coombes

|Jun 04, 2025
Alcohol Use Disorder Associated Gene <i>FNDC4</i> Alters Glutamatergic and GABAergic Neurogenesis.

Xiujuan Zhu, August J John, Li Wang

|Feb 14, 2025
Lysosomal NKG7 restrains mTORC1 activity to promote CD8<sup>+</sup> T cell durability and tumor control.

Hyoungjun Ham, Jacob B Hirdler, Daniel T Bihnam

|Nov 20, 2024
Nuclear receptor-SINE B1 network modulates expanded pluripotency in blastoids and blastocysts.

Ka Wai Wong, Yingying Zeng, Edison Tay

|Mar 27, 2024
Molecular mechanisms involved in alcohol craving, IRF3, and endoplasmic reticulum stress: a multi-omics study.

Ming-Fen Ho, Cheng Zhang, Irene Moon

|Nov 20, 2023
Phase I Study of Elraglusib (9-ING-41), a Glycogen Synthase Kinase-3β Inhibitor, as Monotherapy or Combined with Chemotherapy in Patients with Advanced Malignancies.

Benedito A Carneiro, Ludimila Cavalcante, Devalingam Mahalingam

Pageof 5

Frequent Collaborators

5 joint publications

Victor M Karpyak

5 joint publications

Richard Weinshilboum

5 joint publications

Joanna M Biernacka

4 joint publications

Darren J Baker